"Booklet based vestibular rehabilitation for chronic dizziness is a simple and cost effective means of improving patient reported outcomes in primary care."
Clinical and cost effectiveness of booklet based vestibular rehabilitation for chronic dizziness in primary care: single blind, parallel group, pragmatic, randomised controlled trial
L Yardley, F Barker, I Muller, D Turner, S Kirby, M Mullee, A Morris, P Little
British Medical Journal, 2012, 344:e2237
Read more here.
This blog has been created to bring together different sources of information related to QIPP (Quality, Innovation, Productivity, Prevention).
Showing posts with label cost effectiveness. Show all posts
Showing posts with label cost effectiveness. Show all posts
Thursday, 7 June 2012
Dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease
"Daily dark chocolate consumption could be an effective cardiovascular preventive strategy in this population."
The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model
E Zomer, A Owen, DJ Magliano, D Liew, CM Reid
British Medical Journal, 2012, 344:e3657
Read more here.
The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model
E Zomer, A Owen, DJ Magliano, D Liew, CM Reid
British Medical Journal, 2012, 344:e3657
Read more here.
Monday, 6 February 2012
Better value for money in healthcare
"The United Kingdom appears to have controlled healthcare costs much more effectively than Canada, without significantly reducing the quality of care."
Better value for money in healthcare: European lessons for Canada
A Blomqvist, C Busby
C.D. Howe Institute
January 2012
Read more here.
Better value for money in healthcare: European lessons for Canada
A Blomqvist, C Busby
C.D. Howe Institute
January 2012
Read more here.
Tuesday, 24 January 2012
Paying for "end-of-life" drugs in Australia, Germany, and the United Kingdom
"This issue brief compares U.K., Australian, and German policies on coverage of end-of-life medicines, particularly those that are not curative and offer modest increments in median survival rates."
Paying for "end-of-life" drugs in Australia, Germany, and the United Kingdom: balancing policy, pragmatism, and societal values
Issues in International Health Policy
The Commonwealth Fund
January 2012
Read more here.
Paying for "end-of-life" drugs in Australia, Germany, and the United Kingdom: balancing policy, pragmatism, and societal values
Issues in International Health Policy
The Commonwealth Fund
January 2012
Read more here.
Subscribe to:
Posts (Atom)